FDA Adverse Event Malfunction Summary report: N

IMMULITE 2000 RUBELLA IGM

MDR report key: 5924718 · Received September 2, 2016

Report

Report Number
2432235-2016-00441
Event Type
Malfunction
Date Received
September 2, 2016
Date of Event
February 23, 2016
Report Date
September 2, 2016
Manufacturer
SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS LIMITED
Product Code
LFX
PMA / PMN Number
K012077
Removal / Correction Number
2432235-08/25/2016-002-R
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
IL, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

SIEMENS HEALTHCARE DIAGNOSTICS HAS CONFIRMED THE RUBELLA IGM REAGENT LOTS D236M, D238, 236M, 237, 238, 239, AND 239L ON THE IMMULITE 2000/IMMULITE 2000 XPI SYSTEMS AND REAGENT LOTS 333, AND 334 ON THE IMMULITE/IMMULITE 1000 SYSTEMS EXHIBIT INCREASED IMPRECISION ON PATIENT SAMPLES. SIEMENS INTERNAL INVESTIGATION DEMONSTRATE THAT SOME PATIENT SAMPLES EXHIBIT HIGHER PERCENT COEFFICIENT OF VARIATION (%CV) THAN THE PRECISION PERFORMANCE PUBLISHED IN THE INSTRUCTIONS FOR USE (IFU) FOR THIS ASSAY. QUALITY CONTROLS PROVIDED IN THE RUBELLA IGM KIT MAY NOT DETECT THE IMPRECISION WITH PATIENT RESULTS. AN URGENT FIELD SAFETY NOTICE (UFSN) (B)(4) WAS SENT TO OUS CUSTOMERS AND A URGENT MEDICAL DEVICE RECALL (UMDR) (B)(4) WAS SENT TO US CUSTOMERS IN AUGUST OF 2016. THE UFSN AND UMDR STATE THAT CUSTOMERS ARE TO DISCONTINUE AND DISCARD THE KITS LOTS AFFECTED, AND TO REQUEST A REPLACEMENT LOT. SIEMENS RECOMMENDS TRANSITIONING TO IMMULITE/1000 RUBELLA IGM KIT LOT 0337 AND ABOVE OR TO IMMULITE 2000/2000 XPI RUBELLA IGM KIT LOT 240 AND ABOVE.

Description of Event or Problem · 1

THE CUSTOMER HAS INDICATED THAT THEY ARE OBTAINING AN INCREASE IN POSITIVE AND INDETERMINATE RESULTS FOR RUBELLA IGM ASSAY ON THE IMMULITE 2000 INSTRUMENT WHEN USING KIT LOT 238. THE SAMPLES WERE REPEATED ON AN ALTERNATE PLATFORM AND THE RESULTS WERE NEGATIVE. RESULTS ON FOUR PATIENT SAMPLES WAS PROVIDED BY THE CUSTOMER. IT IS UNKNOWN IF ANY OF THE RESULTS WERE PROVIDED TO THE PHYSICIAN(S). THERE WERE NO REPORTS OF PATIENT INTERVENTION OR ADVERSE HEALTH CONSEQUENCES DUE TO THE INCREASE IN POSITIVE AND INDETERMINATE RESULTS FOR THE RUBELLA IGM ASSAY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
577472 IMMULITE 2000 RUBELLA IGM IMMULITE 2000 RUBELLA IGM LFX SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS LIMITED IMMULITE 2000 RUBELLA IGM 238

Patients

Seq Age Sex Outcome Treatment
1